Treatment of Recurrent Esophageal Cancer

Introduction to Treatment Options

• The British Journal of Cancer recommends chemotherapy as the primary option for patients with good performance status and resected primary tumors 1
• For patients with poor performance status, symptomatic treatment is standard, focusing on quality of life measures and supportive care 1

Treatment Algorithm Based on Clinical Scenario

• The British Journal of Cancer suggests combination chemoradiotherapy followed by chemotherapy alone as a therapeutic option for patients with good performance status and unresected primary tumors 1
• Alternative options include endoscopic treatment for dysphagia and/or chemotherapy 1
• The RTOG schedule is relevant, with four cycles of 5-FU-cisplatin and concurrent radiotherapy 50 Gy in 25 fractions over 5 weeks 2

Site-Specific Recurrence Patterns

• No standard treatment exists for locoregional recurrence, but options include chemotherapy, combination chemoradiotherapy, and endoscopic treatments 1
• Patient enrollment in therapeutic trials is strongly recommended 1

Palliative Interventions for Symptom Control

• Placement of esophageal and/or tracheo-bronchial stent is standard treatment for tracheoesophageal fistula 1
• Double stenting provides better palliation and fewer recurrences 3
• Critical pitfall: Place airway stent before esophageal stent to avoid worsening airway compromise 3

Nutritional Support

• Ensure adequate hydration and nutritional support with consideration of percutaneous gastrostomy tubes if oral intake is compromised 3
• Nutritional support should be provided before initiating chemotherapy or radiation therapy 4

Salvage Surgery for Recurrent Esophageal Carcinoma

Surgical Salvage Option

• Salvage surgery may be offered to highly selected patients with isolated anastomotic recurrence of esophageal carcinoma, although it is associated with high peri‑operative morbidity. 5